An Open-label, Phase 1/2 Trial of Gene Therapy 4D-125 in Males with X-linked Retinitis Pigmentosa (XLRP) Caused by Mutations in the RPGR Gene
This Study is
No Longer Enrolling
Details
Age
Adult
Type of Study
Treatment
Locations
University of Colorado Hospital
Study ID
Protocol Number: 20-0130
More information available at ClinicalTrials.gov: NCT04517149
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers